Association Between Immune-Related Adverse Events During Anti–PD-1 Therapy and Tumor Mutational Burden
JAMA Oncology - United States
doi 10.1001/jamaoncol.2019.3221
Full Text
Open PDFAbstract
Available in full text
Date
November 1, 2019
Authors
Publisher
American Medical Association (AMA)